MEDICINES CO /DE·4

Feb 7, 6:20 PM ET

MEDICINES CO /DE 4

4 · MEDICINES CO /DE · Filed Feb 7, 2017

Insider Transaction Report

Form 4
Period: 2017-02-03
Transactions
  • Exercise/Conversion

    Common Stock

    2017-02-03$22.04/sh+10,833$238,75930,935 total
  • Sale

    Common Stock

    2017-02-03$45.00/sh10,833$487,48520,102 total
  • Exercise/Conversion

    Common Stock

    2017-02-07$28.60/sh+15,000$429,00035,102 total
  • Sale

    Common Stock

    2017-02-07$46.98/sh12,100$568,45823,002 total
  • Sale

    Common Stock

    2017-02-07$47.45/sh2,900$137,60520,102 total
  • Exercise/Conversion

    Stock Option (right-to-buy)

    2017-02-0310,8330 total
    Exercise: $22.04Exp: 2022-02-24Common Stock (10,833 underlying)
  • Exercise/Conversion

    Stock Option (right-to-buy)

    2017-02-0715,0000 total
    Exercise: $28.60Exp: 2017-02-16Common Stock (15,000 underlying)
Footnotes (6)
  • [F1]Sales were effected pursuant to a Rule 10b5-1 program adopted by the reporting person.
  • [F2]Represents the weighted average sales price of the shares sold ranging from a low of $46.35 to a high of $47.34 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  • [F3]Represents the weighted average sales price of the shares sold ranging from a low of $47.35 to a high of $47.67 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  • [F4]This option vested in forty-eight equal monthly installments beginning March 24, 2012.
  • [F5]This option vested in forty-eight equal monthly installments beginning March 16, 2007.
  • [F6]Not applicable.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -